Insiders Indaptus Therapeutics, Inc.

Equities

INDP

US45339J1051

Market Closed - Nasdaq Other stock markets 21:30:01 13/05/2024 BST			5-day change	1st Jan Change
2.12 ^USD	-1.40%		+4.43%	+20.45%

05-08	Indaptus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-14	Top Premarket Gainers	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indaptus Therapeutics, Inc. Appoints Roger Waltzman as Its Chief Medical Officer, Effective August 7, 2023	08/08/23	CI
Indaptus Therapeutics’ Chief Scientific Officer Michael Newman, Ph.D. Named a Chair of the 4th STING & TLR-Targeting Therapies Summit	01/05/23	AQ
Indaptus Therapeutics, Inc. Announces Executive Changes	23/03/23	CI
Indaptus Therapeutics, Inc. Names Robert Martell, M.D., Ph.D. to Its Board of Directors	14/02/23	CI
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer, Effective January 31, 2022	03/01/22	CI
Indaptus Therapeutics, Inc. Announces Board of Director Changes	01/12/21	CI
Indaptus Therapeutics, Inc. Announces Management Changes	06/08/21	CI
Intec Pharma Ltd Announces Board Changes	22/06/21	CI
Intec Pharma Ltd Announces Resignation of Nadav Navon as Chief Operating Officer	08/02/21	CI
Intec Pharma Ltd. Announces Termination of Dr. R. Michael Gendreau as Chief Medical Officer, Effective on October 31, 2020	02/10/20	CI
Intec Pharma Appoints William Bradley Hayes to Board of Directors	29/06/18	CI
Intec Pharma LTD Appoints Roger J. Pomerantz as Board of Directors	26/03/18	CI
Intec Pharma Ltd. Names R. Michael Gendreau as Chief Medical Officer	31/01/18	CI
Intec Pharma, Ltd. Announces Changes to its Board of Directors	01/11/17	CI
Intec Pharma Ltd. Names Walt Linscott to the Position of Chief Administrative Officer	26/10/17	CI
Intec Pharma Ltd. Promotes Nadav Navon to Chief Operating Officer	27/07/17	CI
Intec Pharma Ltd. Appoints Jeffrey A. Meckler as Chief Executive Officer	10/07/17	CI
Intec Pharma Ltd. Announces Management Changes	03/05/17	CI
Intec Pharma Ltd. Appoints Jeffrey A. Meckler as Vice Chairman of its Board of Directors	09/04/17	CI
Intec Pharma Ltd. Nominates John W. Kozarich to Act as Chairman	16/05/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Indaptus Therapeutics, Inc.

Equities

INDP

US45339J1051

Insiders

Filters